VOR
VOR
NASDAQ · Biotechnology

Vor Biopharma Inc

$18.41
-0.19 (-1.02%)
As of Jun 30, 10:20 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 11 85%
Hold 2 15%
Sell 0 0%
Price Target
Analyst Price Target +88.7% upside
Low Target $25.90
Average Target $34.74
High Target $38.60
Current Price $18.41
Current
$18.41
Target
$34.74
$25.90 $34.74 avg $38.60
Scenario Analysis
Bear Case
$25.90
40.7%
Low target
Base Case
$34.74
+88.7%
Avg target
Bull Case
$38.60
+109.7%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$65.80
-72.0% from high
52-Week Low
$5.80
+217.4% from low
Target vs 52W High
$34.74
-47.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%